Skip to content

event

Friends of Cancer Research Annual Meeting 2022

news

New Manuscript Shows Changes in ctDNA Reflect Clinical Benefit to Patients

publication

Statement From Friends of Cancer Research on Monica Bertagnolli’s Nomination as Director of The National Cancer Institute

news

Cancer Network – Roy S. Herbst, MD, PhD, Examines the Use of Ramucirumab Plus Pembrolizumab in ICI-Resistant Advanced NSCLC

news

Bloomberg Law – First Woman Tapped by White House to Head Cancer Institute

news

The Cancer Letter – White House to appoint Monica Bertagnolli as 16th NCI director

news

Statement From Friends of Cancer Research on Monica Bertagnolli’s Nomination as Director of The National Cancer Institute

news

Politico – Clinton-era FDA commissioner to lead external review of key agency offices

news

GenomeWeb – Stakeholders Urge Collaboration to Prove ctDNA as Regulatory Endpoint for Early Cancer Drugs

news

The Pew Charitable Trusts – Senate Committee Advances Legislation to Strengthen Oversight of Diagnostic Tests